Replies to post #238043 on Amarin Corp Plc (AMRN)

[Jamaalish]

Mass, sorry I missed reading your rebuttal. Great response. That would be pretty cool if he replies back to you and it starts a conversation!

[MontanaState83]

I sent a rebuttal as well. Probably too soft but here it is. No reply as yet.

David,

With all due respect, you need to educate yourself a little before writing about Vascepa. While Vascepa (icosapent ethyl) is derived from fish oil, it is no more fish oil than aspirin is tree bark or penicillin is mold. Regarding the cost of Vascepa, are you familiar with the economic assessment done by the Institute for Clinical and Economic Review (ICER)? Vascepa is extremely cost effective. Looking backwards, you may be correct about insurance coverage. However, Vascepa just received its FDA label for CV risk reduction. Insurance coverage will follow (already is).

Not meaning to rag on you, but this is the single biggest breakthrough in cardiovascular space since statins. Nothing else has even come close. Without question, Vascepa is the number 1 finding of 2019.

Have a happy new year,

Tim